Zacks Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Buy
32,627
+1,775
+6% +$121K 0.02% 341
2026
Q1
$1.99M Buy
30,852
+4,421
+17% +$312K 0.02% 352
2025
Q4
$1.78M Buy
26,431
+310
+1% +$20.9K 0.01% 368
2025
Q3
$1.92M Buy
+26,121
New +$1.74M 0.02% 333
2022
Q1
Sell
-37,027
Closed -$1.49M 618
2021
Q4
$1.49M Buy
37,027
+2,222
+6% +$82.9K 0.02% 327
2021
Q3
$1.42M Buy
34,805
+3,302
+10% +$138K 0.02% 328
2021
Q2
$1.43M Buy
31,503
+154
+0.5% +$6.82K 0.02% 324
2021
Q1
$1.31M Buy
31,349
+528
+2% +$24.1K 0.02% 332
2020
Q4
$1.32M Buy
30,821
+4,114
+15% +$148K 0.02% 318
2020
Q3
$702K Sell
26,707
-267
-1% -$7.43K 0.01% 364
2020
Q2
$723K Buy
+26,974
New +$609K 0.02% 354

Other funds holding HALO

Zacks Investment Management's HALO Position: Q2 2026 in Review

Zacks Investment Management increased its Halozyme (HALO) stake by 5.8% in Q2 2026, buying an estimated $121K and bringing the position to 32,627 shares worth $2.55M. The position accounts for 0.02% of the portfolio, ranked #341.

Zacks Investment Management first reported a position in HALO in Q2 2020 and has held it in 11 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Zacks Investment Management held 32,627 shares of Halozyme worth $2.55M as of Q2 2026.
  • Zacks Investment Management bought 1,775 Halozyme shares in Q2 2026, an estimated $121K.
  • Halozyme made up 0.02% of Zacks Investment Management's portfolio in Q2 2026, its #341 holding.
  • Zacks Investment Management first reported a position in Halozyme in Q2 2020 and has held it in 11 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.